Regentatlantic Capital LLC Dexcom Inc Transaction History
Regentatlantic Capital LLC
- $3.34 Billion
- Q3 2022
A detailed history of Regentatlantic Capital LLC transactions in Dexcom Inc stock. As of the latest transaction made, Regentatlantic Capital LLC holds 18,871 shares of DXCM stock, worth $1.26 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
18,871
Previous 17,136
10.12%
Holding current value
$1.26 Million
Previous $1.28 Million
19.03%
% of portfolio
0.05%
Previous 0.04%
Shares
9 transactions
Others Institutions Holding DXCM
# of Institutions
1,113Shares Held
365MCall Options Held
4.1MPut Options Held
3.65M-
Vanguard Group Inc Valley Forge, PA46.5MShares$3.12 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.31 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.3MShares$1.09 Billion0.08% of portfolio
-
Baillie Gifford & CO15.3MShares$1.03 Billion1.38% of portfolio
-
Capital Research Global Investors Los Angeles, CA11.9MShares$801 Million0.31% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $25.9B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...